NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Cannabis Stocks
Buy This 1 Cannabis Stock for Longer-Term Growth Potential

Cannabis Stocks
Aphria and Tilray Stock: So Hot You’ll Get Burned?
Cannabis Stocks
Cannabis 2.0: Is Cannabis Set to Comeback in 2021?

Cannabis Stocks
Tilray and Aphria Merger: A Hot New Pot Stock Opportunity?

Stocks for Beginners
Aphria-Tilray Merger: Is the Cannabis Trade About to Heat Up Again?

Cannabis Stocks
Buy Alert: These 3 Cannabis Stocks Are on Sale Right Now

Cannabis Stocks
2 Canadian Millionaire-Maker Stocks Only Found on the NASDAQ

Cannabis Stocks
Forget Aurora Cannabis (TSX:ACB) and Invest in This Marijuana Stock Instead!

Cannabis Stocks
Coronavirus Impact: What Will Happen to Canada’s Marijuana Stocks?

Cannabis Stocks
Better Cannabis Buy in 2020: Aurora Cannabis (TSX:ACB) Vs. Tilray (NASDAQ:TLRY)

Cannabis Stocks
3 Cannabis Developments Investors Need to Know About Today
